Impact News +++ SITE Centers stock cut to Neutral at Piper Sandler after revised NAV estimate (SeekingAlpha) +++ SITE CENTERS Aktie -3,26%

ELANCO Aktie

>ELANCO Aktienkurs

22.25 EUR +0.2% (TradegateBSX)

Ask: 22.45 EUR / 100 Stück

Bid: 22.225 EUR / 100 Stück

Tagesumsatz: 300 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

ELANCO Aktie über LYNX handeln

Intraday

1 Jahr

>ELANCO Performance

1 Woche: +3,7%

1 Monat: +7,3%

3 Monate: +7,7%

6 Monate: +44,8%

1 Jahr: +105,6%

laufendes Jahr: +14,9%

>ELANCO Aktie

Name:

ELANCO ANIMAL HEALTH.

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US28414H1032 / A2N6BH

Symbol/ Ticker:

5EA (Frankfurt) / ELAN (NYSE)

Kürzel:

FRA:5EA, ETR:5EA, 5EA:GR, NYSE:ELAN

Index:

Webseite:

https://www.elanco.com/

Profil:

Elanco Animal Health Incorporated is a leading global pharmaceutical company specializing in animal health. Its primary function is the development and delivery of innovative products and solutions to..
>Volltext..

Marktkapitalisierung:

11305.16 Mio. EUR

Unternehmenswert:

14368.25 Mio. EUR

Umsatz:

3994.59 Mio. EUR

EBITDA:

789.6 Mio. EUR

Nettogewinn:

-196.55 Mio. EUR

Gewinn je Aktie:

-0.4 EUR

Schulden:

3508.3 Mio. EUR

Liquide Mittel:

461.73 Mio. EUR

Operativer Cashflow:

474.44 Mio. EUR

Bargeldquote:

0.34

Umsatzwachstum:

-6.38%

Gewinnwachstum:

-160.5%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

ELANCO

Letzte Datenerhebung:

27.02.26

>ELANCO Kennzahlen

Aktien/ Unternehmen:

Aktien: 497.17 Mio. St.

Frei handelbar: 99.08%

Leerverk. Aktien: 3.71%

Rückkaufquote: -

Mitarbeiter: 9900

Umsatz/Mitarb.: 0.4 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 8.3%

Bewertung:

KGV: -

KGV lG: 25.67

KUV: 2.86

KBV: 1.99

PEG-Ratio: -

EV/EBITDA: 18.2

Rentabilität:

Bruttomarge: 43.48%

Gewinnmarge: -4.92%

Operative Marge: 5.34%

Managementeffizenz:

Gesamtkaprendite: -1.79%

Eigenkaprendite: -3.67%

>ELANCO Peer Group

Gesundheit, Tiermedizin/ Tierbehandlung

>ELANCO Chart & Kurs - NYSE

>ELANCO News

26.02.26 - 19:24	Elanco auf dem BofA Securities Summit: Strategisches Wachstum im Fokus/n (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

24.02.26 - 18:42	Elanco targets $1.15B innovation revenue in 2026 as Big 6 launches gain momentum (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

24.02.26 - 16:48	Elanco hits 52-week high after Q4 results as 2026 outlook beats consensus (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

24.02.26 - 16:45	Elanco Animal Health (ELAN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
	While the top- and bottom-line numbers for Elanco Animal Health (ELAN) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....

24.02.26 - 16:24	Elanco (ELAN) Q4 2025 Earnings Call Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

24.02.26 - 16:00	Elanco Animal Health Incorporated (ELAN) Q4 Earnings and Revenues Surpass Estimates (Zacks)
	Elanco Animal Health (ELAN) delivered earnings and revenue surprises of +16.07% and +4.72%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...

24.02.26 - 13:12	Elanco Animal Health Q4 Loss Sharply Widens; Sees Grown In FY26 (AFX)
	WASHINGTON (dpa-AFX) - Elanco Animal Health, Inc. (ELAN) reported Tuesday a net loss of $276 million or $0.56 per share for the fourth quarter, sharply wider than $8 million or $0.02 per share in ......

24.02.26 - 12:33	Elanco Non-GAAP EPS of $0.13 beats by $0.02, revenue of $1.14B beats by $50M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

24.02.26 - 12:30	Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results (PR Newswire)
	Raising 2026 Innovation Target; Full Year 2026 Guidance of 4%-6% Organic Constant Currency Revenue Growth, 6%-9% Adjusted EBITDA Growth In Line with Investor Day Outlook Fourth Quarter 2025 Financial Results: Revenue of $1,144 million, increased 12% on a reported basis; 9% in organic......

23.02.26 - 16:12	Elanco Q4 2025 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

13.02.26 - 16:12	Elanco board shrinks as two members opt out of reelection (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

13.02.26 - 15:27	Elanco Announces Updates to Board of Directors (PR Newswire)
	INDIANAPOLIS, Feb. 13, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced updates to its Board of Directors. R. David Hoover and Deborah Kochevar will not stand for re-election at the conclusion of their terms at the 2026 Annual Meeting of Shareholders in......

30.01.26 - 16:42	Elanco: Protein, Science, Debate and Dietary Guidelines: Nina Teicholz (Accesswire)
	NORTHAMPTON, MA / ACCESS Newswire / January 30, 2026 / By Jeff SimmonsProtein. It's everywhere. From our center of the plate favorites to protein popcorn, ramen to even protein-packed ice cream, it......

22.01.26 - 17:15	Elanco upgraded, Zoetis downgraded at Piper Sandler (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

22.01.26 - 16:51	Piper Sandler upgrades Elanco as co gains traction with veterinary groups (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

22.01.26 - 14:01	Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement (PR Newswire)
	INDIANAPOLIS, Jan. 22, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026. Elanco will also conduct a conference call on that day with the investment community and media to......

13.01.26 - 01:48

Stocks Rise as Credit Card Shares Slip on Trump Rate Cap Talk | The Close 1/12/2026 (Bloomberg)

Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Former Federal Reserve Governor Betsy Duke, GE HealthCare's Peter Arduini, CFRA's Ken Leon, Zoetis' Kristin Peck, Morgan Stanley's Lauren Hochfelder, Blackrock's Jay Jacobs, Cornell University's Eswar Prasad, PGIM's Cathy Marcus, Elanco Animal Health's Jeff Simmons, Pfizer's Albert Bourla. (Source: Bloomberg)...

13.01.26 - 01:01	Elanco CEO: Gaining Market Share Via ′Major′ Innovations (Bloomberg)
	Jeff Simmons, Elanco Animal Health CEO, discusses pet-care growth with Katie Greifeld at the JPMorgan Healthcare Conference on “The Close.” He says the company is focused on pets, cattle and poultry. (Source: Bloomberg)...

06.01.26 - 14:03	Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
	INDIANAPOLIS, Jan. 6, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026. Jeff Simmons, president and CEO, and Bob VanHimbergen, executive vice president and CFO, will......

01.01.26 - 07:18	Elanco Secures USDA Approval For Befrena, Expands Dermatology Portfolio (AFX)
	WASHINGTON (dpa-AFX) - Elanco Animal Health Inc. (ELAN) announced that the U.S. Department of Agriculture (USDA) has approved Befrena (tirnovetmab), a new anti-IL31 monoclonal antibody injection d......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Das Leben ein Gedicht! Nein! Nicht wenn man nur umherging und an seinem Leben herumdichtete, anstatt es zu leben. - Jens Peter Jacobsen

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram